(Q40964242)
Statements
Tumorigenicity of mouse thymoma is suppressed by soluble type II transforming growth factor beta receptor therapy (English)
Won J
Kim H
Park EJ
Hong Y
Kim SJ
1 March 1999
scientific article published on March 1999